Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
37.44
-0.04 (-0.11%)
At close: Jul 2, 2026, 4:00 PM EDT
37.31
-0.13 (-0.35%)
After-hours: Jul 2, 2026, 7:56 PM EDT
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $4.35 billion as of July 2, 2026. Its market cap has increased by 46.45% in one year.
Market Cap
4.35B
Enterprise Value
3.74B
1-Year Change
46.45%
Ranking
Category
Stock Price
$37.44
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $4.35B, an increase of 5,509.03%. That is a compound annual growth rate of 43.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 4.35B | 9.31% |
| Dec 31, 2025 | 3.98B | -11.32% |
| Dec 31, 2024 | 4.48B | 140.89% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
| Apr 29, 2015 | 77.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 4.45B |
| ACADIA Pharmaceuticals | 4.45B |
| Tango Therapeutics | 4.26B |
| Edgewise Therapeutics | 4.26B |
| Denali Therapeutics | 4.10B |
| NewAmsterdam Pharma Company | 4.07B |
| Relay Therapeutics | 4.06B |
| Telix Pharmaceuticals | 3.97B |